Zhao Li , Di Wang , Lei Jin , Jie Zhang , Tao Xue , Lei Jin
{"title":"母亲暴露于空气中的细颗粒物与胎儿先天性心脏缺陷的风险:一项病例对照研究。","authors":"Zhao Li , Di Wang , Lei Jin , Jie Zhang , Tao Xue , Lei Jin","doi":"10.1016/j.reprotox.2024.108816","DOIUrl":null,"url":null,"abstract":"<div><div>Prior research into the association between fine particulate matter (PM<sub>2.5</sub>) exposure and the risk for fetal congenital heart defect (CHD) has yielded inconclusive and conflicting results. More epidemiologic evidence from different regions is necessary. A case-control study was conducted with 360 CHD cases and 3600 healthy newborns. Both the cases and the controls were registered by the mothers in the Prenatal Health Care System during the first trimester and gave birth at hospitals in the Tongzhou District of Beijing between 2013 and 2018. Information on PM<sub>2.5</sub> was obtained from satellite remote sensing monitoring data. We estimated average monthly PM<sub>2.5</sub> exposure for participants from 3 months before the last menstrual period through 6 months of gestational period. A logistic regression model was used to estimate odd ratio (OR) (95 % confidence interval, CI) for PM<sub>2.5</sub> exposure level and fetal risk for CHD. In our study, PM<sub>2.5</sub> concentrations before pregnancy and in the first trimester were not associated with CHD risk. In the second trimester, 2nd high quartile PM<sub>2.5</sub> group during the second month were associated with a lower CHD risk (adjusted OR(aOR)= 1.42, 95 % CI: 1.04–1.94) and highest quartile level group of PM<sub>2.5</sub> exposure in the third month were associated with a reduced risk for fetal CHD (aOR=0.70, 95 % CI: 0.51–0.97). After Bonferroni’s α correction, no comparisons were statistically significant. In conclusion, no associations were found between PM<sub>2.5</sub> exposure level and fetal risk for CHD in our study.</div></div>","PeriodicalId":21137,"journal":{"name":"Reproductive toxicology","volume":"132 ","pages":"Article 108816"},"PeriodicalIF":3.3000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maternal exposure to fine particulate matter in the air and risk for fetal congenital heart defects: A case-control study\",\"authors\":\"Zhao Li , Di Wang , Lei Jin , Jie Zhang , Tao Xue , Lei Jin\",\"doi\":\"10.1016/j.reprotox.2024.108816\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Prior research into the association between fine particulate matter (PM<sub>2.5</sub>) exposure and the risk for fetal congenital heart defect (CHD) has yielded inconclusive and conflicting results. More epidemiologic evidence from different regions is necessary. A case-control study was conducted with 360 CHD cases and 3600 healthy newborns. Both the cases and the controls were registered by the mothers in the Prenatal Health Care System during the first trimester and gave birth at hospitals in the Tongzhou District of Beijing between 2013 and 2018. Information on PM<sub>2.5</sub> was obtained from satellite remote sensing monitoring data. We estimated average monthly PM<sub>2.5</sub> exposure for participants from 3 months before the last menstrual period through 6 months of gestational period. A logistic regression model was used to estimate odd ratio (OR) (95 % confidence interval, CI) for PM<sub>2.5</sub> exposure level and fetal risk for CHD. In our study, PM<sub>2.5</sub> concentrations before pregnancy and in the first trimester were not associated with CHD risk. In the second trimester, 2nd high quartile PM<sub>2.5</sub> group during the second month were associated with a lower CHD risk (adjusted OR(aOR)= 1.42, 95 % CI: 1.04–1.94) and highest quartile level group of PM<sub>2.5</sub> exposure in the third month were associated with a reduced risk for fetal CHD (aOR=0.70, 95 % CI: 0.51–0.97). After Bonferroni’s α correction, no comparisons were statistically significant. In conclusion, no associations were found between PM<sub>2.5</sub> exposure level and fetal risk for CHD in our study.</div></div>\",\"PeriodicalId\":21137,\"journal\":{\"name\":\"Reproductive toxicology\",\"volume\":\"132 \",\"pages\":\"Article 108816\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0890623824002831\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"REPRODUCTIVE BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive toxicology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0890623824002831","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
Maternal exposure to fine particulate matter in the air and risk for fetal congenital heart defects: A case-control study
Prior research into the association between fine particulate matter (PM2.5) exposure and the risk for fetal congenital heart defect (CHD) has yielded inconclusive and conflicting results. More epidemiologic evidence from different regions is necessary. A case-control study was conducted with 360 CHD cases and 3600 healthy newborns. Both the cases and the controls were registered by the mothers in the Prenatal Health Care System during the first trimester and gave birth at hospitals in the Tongzhou District of Beijing between 2013 and 2018. Information on PM2.5 was obtained from satellite remote sensing monitoring data. We estimated average monthly PM2.5 exposure for participants from 3 months before the last menstrual period through 6 months of gestational period. A logistic regression model was used to estimate odd ratio (OR) (95 % confidence interval, CI) for PM2.5 exposure level and fetal risk for CHD. In our study, PM2.5 concentrations before pregnancy and in the first trimester were not associated with CHD risk. In the second trimester, 2nd high quartile PM2.5 group during the second month were associated with a lower CHD risk (adjusted OR(aOR)= 1.42, 95 % CI: 1.04–1.94) and highest quartile level group of PM2.5 exposure in the third month were associated with a reduced risk for fetal CHD (aOR=0.70, 95 % CI: 0.51–0.97). After Bonferroni’s α correction, no comparisons were statistically significant. In conclusion, no associations were found between PM2.5 exposure level and fetal risk for CHD in our study.
期刊介绍:
Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.
All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.